HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. (Q43438121)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Antonella Ravaggi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Alessandro D Santin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Stefania Bellone

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Michela Palmieri

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Renata Tassi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Juan J Roman

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alexander Burnett

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sergio Pecorelli

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Martin J Cannon

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

0 references

publication date

24 October 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

100

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

469-478

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16249018%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Dendritic cells as adjuvants for immune-mediated resistance to tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Loss of MHC class-I expression in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Immunology. Licence to kill.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

A fail-safe mechanism for maintaining self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

CD4+8- help prevents rapid deletion of CD8+ cells after a transient response to antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Immunocompetent for immunotherapy? A study of the immunocompetence of cervical cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.040

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43438121&oldid=2043603211"